Loading insider details...
Beta
Latest Form 4 (Jan 13, 2026): Grant/Award of 24,615 COCP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 13, 2026 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 24,615 | n/a |
| Jan 5, 2026 | Xenetic Biosciences, Inc. (XBIO) | Grant/Award | 2,500 | n/a |
| Dec 13, 2024 | Xenetic Biosciences, Inc. (XBIO) | Grant/Award | 2,500 | n/a |
| Oct 11, 2024 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 28,109 | n/a |
| Dec 8, 2023 | Xenetic Biosciences, Inc. (XBIO) | Grant/Award | 2,500 | n/a |
| Jul 20, 2023 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 24,417 | n/a |
| Dec 9, 2022 | Xenetic Biosciences, Inc. (XBIO) | Grant/Award | 25,000 | n/a |
| Aug 3, 2022 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 280,000 | n/a |
| Dec 9, 2021 | Xenetic Biosciences, Inc. (XBIO) | Grant/Award | 25,000 | n/a |
| Jul 20, 2021 | Cocrystal Pharma, Inc. (COCP) | Grant/Award | 65,000 | n/a |